MyFinsight
Home
Blog
About
Inhibikase Therapeutics, Inc. (IKT)
Inhibikase Therapeutics, Inc. (IKT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-12,443,612
-12,059,722
-7,515,973
-10,592,730
Return on Equity
-12.777
-9.773
-8.959
-16.366
Debt to Asset Ratio
6.272
3.295
4.581
8.413
Quick Ratio
1,582.295
3,014.316
2,169.774
1,172.846
Current Ratio
1,582.295
3,014.316
2,169.774
1,172.846
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.